Eli Lilly E-Mail Discussed Unapproved Use of Drug
15 maart 2008
John C. Lechleiter, an Eli Lilly official who is about to become the company’s top executive, wrote an e-mail message in 2003 that appears to have encouraged Lilly to promote its schizophrenia medicine Zyprexa for a use not approved by federal drug regulators.
Bron: New York Times
| < Vorige | Volgende > |
|---|
